Fresenius Has Not Certified Compliance for NxStage Medical Acquisition

CTFN confirmed with a source close to the deal that Fresenius has not certified substantial compliance with the U.S. Federal Trade Commission’s second request, as some marketfeatured

Ex-Trump Aide’s Comments on Time Warner/AT&T Could Backfire

The filing of an amicus brief by former campaign aide to President Donald Trump, Carter Page, with the court hearing the Department of Justice’s antitrust case against the merger of Time Warner andfeatured

CADE Unlikely to Request Additional Divestments from Monsanto/Bayer

Brazilian antitrust regulator CADE is not expected to request further structural remedies to complement the global divestments publicly announced by the parties that would seefeatured

CADE Launches In-Depth Probe into Luxottica/Essilor

Brazilian antitrust regulator CADE has declared the planned merger between French lens maker Essilor and Italian eyewear manufacturer Luxottica “complex,” in view offeatured

Sinclair Might Look to Swap TV Stations for Tribune Approval

Sinclair Broadcast Group, Inc. might consider swapping TV stations with other broadcasters as a way to comply with the Justice Department’s antitrust concerns over itsfeatured

Small Cable Companies Subdued on Scripps/Discovery

Executives at small cable companies, who have expressed trepidation over the Tribune/Sinclair deal and the rapidly rising cost of retransmission fees, have told CTFN that thefeatured

NXP/Qualcomm EC Approval Most Likely Early-to-Mid January

Competition partners following the NXP/Qualcomm case at the European Commission say that any final decision on Qualcomm and NXP is unlikely this year, thoughfeatured

Judge Directs Time Warner and AT&T to Extend Termination Deadline

Federal Judge Richard Leon told attorneys for AT&T and Time Warner that the companies are going have to extend the April 22 termination date for their merger because hefeatured

Linde/Praxair in Pre-Filing Discussions with CADE

Industrial gas giants Linde and Praxair are currently engaged in pre-notification talks with Brazilian antitrust regulator CADE for their planned $80 billion merger, sourcesfeatured

Monsanto/Bayer Review Likely to Go to Phase Two in India

The Competition Commission of India is likely to move the Monsanto/Bayer deal into Phase Two, sources following the situation believe. Anshuman Sakle, a competition partner at Cyril Amarchand Mangaldas, explained thatfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.